622 related articles for article (PubMed ID: 30753422)
1. PBI-4050 reduces pulmonary hypertension, lung fibrosis, and right ventricular dysfunction in heart failure.
Nguyen QT; Nsaibia MJ; Sirois MG; Calderone A; Tardif JC; Fen Shi Y; Ruiz M; Daneault C; Gagnon L; Grouix B; Laurin P; Dupuis J
Cardiovasc Res; 2020 Jan; 116(1):171-182. PubMed ID: 30753422
[TBL] [Abstract][Full Text] [Related]
2. Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.
Bruce E; Shenoy V; Rathinasabapathy A; Espejo A; Horowitz A; Oswalt A; Francis J; Nair A; Unger T; Raizada MK; Steckelings UM; Sumners C; Katovich MJ
Br J Pharmacol; 2015 May; 172(9):2219-31. PubMed ID: 25522140
[TBL] [Abstract][Full Text] [Related]
3. Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.
Adão R; Mendes-Ferreira P; Santos-Ribeiro D; Maia-Rocha C; Pimentel LD; Monteiro-Pinto C; Mulvaney EP; Reid HM; Kinsella BT; Potus F; Breuils-Bonnet S; Rademaker MT; Provencher S; Bonnet S; Leite-Moreira AF; Brás-Silva C
Cardiovasc Res; 2018 Jul; 114(8):1165-1177. PubMed ID: 29584808
[TBL] [Abstract][Full Text] [Related]
4. Fibroblasts and the extracellular matrix in right ventricular disease.
Frangogiannis NG
Cardiovasc Res; 2017 Oct; 113(12):1453-1464. PubMed ID: 28957531
[TBL] [Abstract][Full Text] [Related]
5. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
[TBL] [Abstract][Full Text] [Related]
6. Rutaecarpine attenuates hypoxia-induced right ventricular remodeling in rats.
Li WQ; Li XH; Du J; Zhang W; Li D; Xiong XM; Li YJ
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):757-67. PubMed ID: 27052575
[TBL] [Abstract][Full Text] [Related]
7. Alterations in cardiovascular function in an experimental model of lung fibrosis and pulmonary hypertension.
Darwiche T; Collum SD; Bi W; Reynolds JO; Wilson C; Wareing N; Hernandez AM; Mertens TCJ; Zhou Z; Pandit LM; Karmouty-Quintana H
Exp Physiol; 2019 Apr; 104(4):568-579. PubMed ID: 30663834
[TBL] [Abstract][Full Text] [Related]
8. Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.
Lambert M; Boet A; Rucker-Martin C; Mendes-Ferreira P; Capuano V; Hatem S; Adão R; Brás-Silva C; Hautefort A; Michel JB; Dorfmuller P; Fadel E; Kotsimbos T; Price L; Jourdon P; Montani D; Humbert M; Perros F; Antigny F
Cardiovasc Res; 2018 May; 114(6):880-893. PubMed ID: 29360952
[TBL] [Abstract][Full Text] [Related]
9. miR-223-IGF-IR signalling in hypoxia- and load-induced right-ventricular failure: a novel therapeutic approach.
Shi L; Kojonazarov B; Elgheznawy A; Popp R; Dahal BK; Böhm M; Pullamsetti SS; Ghofrani HA; Gödecke A; Jungmann A; Katus HA; Müller OJ; Schermuly RT; Fisslthaler B; Seeger W; Fleming I
Cardiovasc Res; 2016 Aug; 111(3):184-93. PubMed ID: 27013635
[TBL] [Abstract][Full Text] [Related]
10. Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure.
Suen CM; Chaudhary KR; Deng Y; Jiang B; Stewart DJ
Cardiovasc Res; 2019 Mar; 115(4):788-799. PubMed ID: 30357319
[TBL] [Abstract][Full Text] [Related]
11. α
Cowley PM; Wang G; Joshi S; Swigart PM; Lovett DH; Simpson PC; Baker AJ
Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1109-H1118. PubMed ID: 28822963
[TBL] [Abstract][Full Text] [Related]
12. Experimental Right Ventricular Hypertension Induces Regional β1-Integrin-Mediated Transduction of Hypertrophic and Profibrotic Right and Left Ventricular Signaling.
Sun M; Ishii R; Okumura K; Krauszman A; Breitling S; Gomez O; Hinek A; Boo S; Hinz B; Connelly KA; Kuebler WM; Friedberg MK
J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29599211
[TBL] [Abstract][Full Text] [Related]
13. Colchicine Depolymerizes Microtubules, Increases Junctophilin-2, and Improves Right Ventricular Function in Experimental Pulmonary Arterial Hypertension.
Prins KW; Tian L; Wu D; Thenappan T; Metzger JM; Archer SL
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28566298
[TBL] [Abstract][Full Text] [Related]
14. Role of aldosterone on lung structural remodelling and right ventricular function in congestive heart failure.
Chabot A; Jiang BH; Shi Y; Tardif JC; Dupuis J
BMC Cardiovasc Disord; 2011 Dec; 11():72. PubMed ID: 22136321
[TBL] [Abstract][Full Text] [Related]
15. Early versus late cardiac remodeling during right ventricular pressure load and impact of preventive versus rescue therapy with endothelin-1 receptor blockers.
Ramos SR; Pieles G; Sun M; Slorach C; Hui W; Friedberg MK
J Appl Physiol (1985); 2018 May; 124(5):1349-1362. PubMed ID: 29446710
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin Receptor-Neprilysin Inhibition Attenuates Right Ventricular Remodeling in Pulmonary Hypertension.
Sharifi Kia D; Benza E; Bachman TN; Tushak C; Kim K; Simon MA
J Am Heart Assoc; 2020 Jul; 9(13):e015708. PubMed ID: 32552157
[TBL] [Abstract][Full Text] [Related]
17. 17β-estradiol preserves right ventricular function in rats with pulmonary arterial hypertension: an echocardiographic and histochemical study.
Wang YD; Li YD; Ding XY; Wu XP; Li C; Guo DC; Shi YP; Lu XZ
Int J Cardiovasc Imaging; 2019 Mar; 35(3):441-450. PubMed ID: 30350115
[TBL] [Abstract][Full Text] [Related]
18. Protection against pressure overload-induced right heart failure by uncoupling protein 2 silencing.
Esfandiary A; Kutsche HS; Schreckenberg R; Weber M; Pak O; Kojonazarov B; Sydykov A; Hirschhäuser C; Wolf A; Haag D; Hecker M; Fink L; Seeger W; Ghofrani HA; Schermuly RT; Weißmann N; Schulz R; Rohrbach S; Li L; Sommer N; Schlüter KD
Cardiovasc Res; 2019 Jun; 115(7):1217-1227. PubMed ID: 30850841
[TBL] [Abstract][Full Text] [Related]
19. Right ventricular cyclic nucleotide signaling is decreased in hyperoxia-induced pulmonary hypertension in neonatal mice.
Heilman RP; Lagoski MB; Lee KJ; Taylor JM; Kim GA; Berkelhamer SK; Steinhorn RH; Farrow KN
Am J Physiol Heart Circ Physiol; 2015 Jun; 308(12):H1575-82. PubMed ID: 25862831
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Pulmonary Hypertension With Angiotensin II Receptor Blocker and Neprilysin Inhibitor Sacubitril/Valsartan.
Clements RT; Vang A; Fernandez-Nicolas A; Kue NR; Mancini TJ; Morrison AR; Mallem K; McCullough DJ; Choudhary G
Circ Heart Fail; 2019 Nov; 12(11):e005819. PubMed ID: 31707802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
